Quipt Home Medical (QIPT) Set to Announce Earnings on Tuesday

Quipt Home Medical (NASDAQ:QIPTGet Rating) is scheduled to announce its earnings results before the market opens on Tuesday, May 17th. Analysts expect the company to announce earnings of $0.03 per share for the quarter.

Quipt Home Medical (NASDAQ:QIPTGet Rating) last released its quarterly earnings data on Monday, February 14th. The company reported ($0.06) EPS for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.08). Quipt Home Medical had a negative net margin of 8.86% and a negative return on equity of 4.36%. The business had revenue of $29.53 million during the quarter, compared to analysts’ expectations of $30.30 million. On average, analysts expect Quipt Home Medical to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

QIPT opened at $4.33 on Tuesday. Quipt Home Medical has a one year low of $4.03 and a one year high of $7.72. The company has a market cap of $145.19 million and a P/E ratio of -13.53. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.38 and a current ratio of 1.70. The business’s 50-day simple moving average is $4.51 and its 200-day simple moving average is $5.23.

A number of large investors have recently added to or reduced their stakes in QIPT. Royal Bank of Canada purchased a new position in Quipt Home Medical during the 2nd quarter worth approximately $35,000. Marshall Wace LLP purchased a new position in Quipt Home Medical during the 4th quarter worth approximately $89,000. Citadel Advisors LLC acquired a new stake in Quipt Home Medical during the 4th quarter worth approximately $97,000. Bank of America Corp DE lifted its position in Quipt Home Medical by 196.7% during the 4th quarter. Bank of America Corp DE now owns 18,545 shares of the company’s stock worth $104,000 after acquiring an additional 12,295 shares during the period. Finally, Susquehanna International Group LLP acquired a new stake in Quipt Home Medical during the 4th quarter worth approximately $119,000. Hedge funds and other institutional investors own 19.42% of the company’s stock.

A number of research firms have recently commented on QIPT. Zacks Investment Research upgraded Quipt Home Medical from a “strong sell” rating to a “hold” rating in a report on Wednesday, March 9th. Raymond James set a $9.00 price objective on Quipt Home Medical and gave the company an “outperform” rating in a report on Thursday, April 28th. One equities research analyst has rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. According to data from MarketBeat, Quipt Home Medical presently has an average rating of “Buy” and an average target price of $9.30.

About Quipt Home Medical (Get Rating)

Quipt Home Medical Corp. provides in-home medical equipment and supplies, and respiratory and durable medical equipment in the United States. The company also offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions.

Featured Articles

Receive News & Ratings for Quipt Home Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quipt Home Medical and related companies with MarketBeat.com's FREE daily email newsletter.